{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1361981468958246784.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1097/01.aog.0000429658.85846.f9"}},{"identifier":{"@type":"URI","@value":"https://journals.lww.com/10.1097/01.AOG.0000429658.85846.f9"}}],"dc:title":[{"@value":"Practice Bulletin No. 134"}],"dcterms:alternative":[{"@value":"Fetal Growth Restriction"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1380017279864531459","@type":"Researcher","foaf:name":[{"@value":"American College of Obstetricians and Gynecologists"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"00297844"}],"prism:publicationName":[{"@value":"Obstetrics & Gynecology"}],"dc:publisher":[{"@value":"Ovid Technologies (Wolters Kluwer Health)"}],"prism:publicationDate":"2013-05","prism:volume":"121","prism:number":"5","prism:startingPage":"1122","prism:endingPage":"1133"},"reviewed":"false","url":[{"@id":"https://journals.lww.com/10.1097/01.AOG.0000429658.85846.f9"}],"createdAt":"2013-04-23","modifiedAt":"2021-11-10","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360002217158797440","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Effect of<i>Porphyromonas gingivalis</i>infection in the placenta and umbilical cord in pregnant mice with low birth weight"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004233490152448","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Tadalafil treatment in mice for preeclampsia with fetal growth restriction has neuro-benefic effects in offspring through modulating prenatal hypoxic conditions"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004235786576256","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Placental mesenchymal dysplasia with severe fetal growth restriction in one placenta of a dichorionic diamniotic twin pregnancy"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004236078278784","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"TADAFER II: Tadalafil treatment for fetal growth restriction - a study protocol for a multicenter randomised controlled phase II trial"}]},{"@id":"https://cir.nii.ac.jp/crid/1360017279864531584","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Outcome of Inducing Labor in Pregnancies with Suspected Fetal Growth Restriction: Oxytocin Discontinuation during the Active Phase of Labor versus Conventional Management"}]},{"@id":"https://cir.nii.ac.jp/crid/1360572092652424192","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Tadalafil Treatment Ameliorates Hypoxia and Alters Placental Expression of Proteins Downstream of mTOR Signaling in Fetal Growth Restriction"}]},{"@id":"https://cir.nii.ac.jp/crid/1360857593808407552","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Sphingolipids and Kidney Disease: Possible Role of Preeclampsia and Intrauterine Growth Restriction (IUGR)"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282680083435392","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Cardiovascular Remodeling and Dysfunction Across a Range of Growth Restriction Severity in Small for Gestational Age Infants　– Implications for Fetal Programming –"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1097/01.aog.0000429658.85846.f9"},{"@type":"CROSSREF","@value":"10.1080/00016357.2018.1426876_references_DOI_MYUK5TXtQdY8iz3k7dHYeYQBq71"},{"@type":"CROSSREF","@value":"10.1038/s41598-018-36084-x_references_DOI_MYUK5TXtQdY8iz3k7dHYeYQBq71"},{"@type":"CROSSREF","@value":"10.1111/jog.13601_references_DOI_MYUK5TXtQdY8iz3k7dHYeYQBq71"},{"@type":"CROSSREF","@value":"10.1136/bmjopen-2017-020948_references_DOI_MYUK5TXtQdY8iz3k7dHYeYQBq71"},{"@type":"CROSSREF","@value":"10.1055/a-1933-7340_references_DOI_MYUK5TXtQdY8iz3k7dHYeYQBq71"},{"@type":"CROSSREF","@value":"10.3390/medicina56120722_references_DOI_MYUK5TXtQdY8iz3k7dHYeYQBq71"},{"@type":"CROSSREF","@value":"10.1253/circj.cj-16-0352_references_DOI_MYUK5TXtQdY8iz3k7dHYeYQBq71"},{"@type":"CROSSREF","@value":"10.34067/kid.0006322020_references_DOI_MYUK5TXtQdY8iz3k7dHYeYQBq71"}]}